Baxter's Mini-bag
Executive Summary
The firm announced agreements covering Upjohn's Cleocin, Pfizer's Cefobid and Roche's once-a-day Rocephin in the firm's premix Mini-bag. Baxter has previously announced agreements for the premix I.V. administration technology with Searle, Phone Poulenx, Merck, SmithKline Beckman, Schering, Hoechst-Roussel and Fujisawa SmithKline.